Home > Compound List > Product Information
Ibutilide_Molecular_structure_CAS_122647-32-9)
Click picture or here to close

Ibutilide

Catalog No. DB00308 Name DrugBank
CAS Number 122647-32-9 Website http://www.ualberta.ca/
M. F. C20H36N2O3S Telephone (780) 492-3111
M. W. 384.57644 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 193

SYNONYMS

IUPAC name
N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide
IUPAC Traditional name
@ibutilide
Brand Name
Corvert
Synonyms
Ibutilide Fumarate
Ibutilidum [INN-Latin]
Ibutilida [INN-Spanish]
Ibutilide

DATABASE IDS

PubChem SID 46507904
CAS Number 122647-32-9
PubChem CID 60753

PROPERTIES

Hydrophobicity(logP) 4.6
Solubility 100 mg/mL

DETAILS

Description (English)
Item Information
Drug Groups approved
Description Ibutilide is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset to sinus rhythm. [Wikipedia]
Indication Indicated for the rapid conversion of atrial fibrillation or atrial flutter of recent onset to sinus rhythm.
Pharmacology Ibutilide prolongs the action potential duration and increases both atrial and ventricular refractoriness in vivo, i.e., class III electrophysiologic effects. Voltage clamp studies indicate that ibutilide, at nanomolar concentrations, delays repolarization by activation of a slow, inward current (predominantly sodium), rather than by blocking outward potassium currents, which is the mechanism by which most other class III antiarrhythmics act.
Toxicity Acute overdose in animals results in CNS toxicity; notably, CNS depression, rapid gasping breathing, and convulsions. The intravenous median lethal dose in the rat was more than 50 mg/kg which is, on a mg/m2 basis, at least 250 times the maximum recommended human dose.
Affected Organisms
Humans and other mammals
Biotransformation Primarily hepatic. Eight metabolites of ibutilide were detected in metabolic profiling of urine. These metabolites are thought to be formed primarily by o-oxidation followed by sequential b-oxidation of the heptyl side chain of ibutilide. Of the eight metabolites, only the o-hydroxy metabolite possesses class III electrophysiologic properties similar to that of ibutilide in an in vitro isolated rabbit myocardium model.
Absorption Rapid after intravenous injection
Half Life 6 hours (ranges from 2-12 hours)
Protein Binding 40%
Elimination In healthy male volunteers, about 82% of a 0.01 mg/kg dose of [14C] ibutilide fumarate was excreted in the urine (about 7% of the dose as unchanged ibutilide) and the remainder (about 19%) was recovered in the feces.
Distribution * 11 L/kg
Clearance * 29 mL/min/kg
External Links
Wikipedia
RxList
Drugs.com

REFERENCES